UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 234

Sortiert nach

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/ serotonin reuptake inhibitor, vilazodone

European journal of pharmacology, 2005-03, Vol.510 (1-2), p.49-57

2005

Volltextzugriff (PDF)

Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

Neuropharmacology, 2006-06, Vol.50 (8), p.975-983

2006

Volltextzugriff (PDF)

Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets

Pharmacology, biochemistry and behavior, 2004-11, Vol.79 (3), p.391-400

2004

Volltextzugriff (PDF)

5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta

European journal of pharmacology, 2004-04, Vol.491 (1), p.77-84

2004

Volltextzugriff (PDF)

SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

European journal of pharmacology, 2006-04, Vol.536 (1-2), p.54-61

2006

Volltextzugriff (PDF)

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist

Neuropharmacology, 2006-06, Vol.50 (8), p.984-990

2006

Volltextzugriff (PDF)

Fluorescence detection of gadolinium chelates separated by reversed-phase high-performance liquid chromatography

Analytical chemistry (Washington), 1988-03, Vol.60 (6), p.514-516

1988

Volltextzugriff (PDF)

Effect of 5-HT 1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets

Pharmacology, biochemistry and behavior, 2004-11, Vol.79 (3), p.391-400

2004

Volltextzugriff (PDF)

Characterisation of the selective 5-HT sub(1B) receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxy indol-1-yl]-1-[2'-methyl-4'- (5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

Neuropharmacology, 2006-06, Vol.50 (8), p.975-983

2006

Volltextzugriff (PDF)

Characterisation of the selective 5-HT 1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

Neuropharmacology, 2006, Vol.50 (8), p.975-983

2006

Volltextzugriff (PDF)

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5- methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)b iphenyl-4 - yl]methanone hydrochloride): A novel, potent and selective 5-HT sub(1B) receptor antagonist

Neuropharmacology, 2006-06, Vol.50 (8), p.984-990

2006

Volltextzugriff (PDF)

SB-616234-A (1-[6-( cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT 1B receptor antagonist

Neuropharmacology, 2006, Vol.50 (8), p.984-990

2006

Volltextzugriff (PDF)

5-HT 7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta

European journal of pharmacology, 2004, Vol.491 (1), p.77-84

2004

Volltextzugriff (PDF)

SB-649915, a novel, potent 5-HT sub(1A) and 5-HT sub(1B) autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

European journal of pharmacology, 2006-01, Vol.536 (1-2), p.54-61

2006

Volltextzugriff (PDF)

SB-649915, a novel, potent 5-HT 1A and 5-HT 1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

European journal of pharmacology, 2006, Vol.536 (1), p.54-61

2006

Volltextzugriff (PDF)

Neurochemical evaluation of the novel 5-HT 1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone

European journal of pharmacology, 2005, Vol.510 (1), p.49-57

2005

Volltextzugriff (PDF)

Prekallikrein Activation, C1 Esterase Inhibitor, and Factor XII as Predictors of Adverse Reaction to Contrast Media: A Prospective Study

Investigative radiology, 1987-06, Vol.22 (6), p.490-494

1987

Volltextzugriff (PDF)

A Predictive Test for Adverse Reactions to Contrast Media Preliminary Results

Investigative radiology, 1988-09, Vol.23 Suppl 1, p.S206-S208

1988

Volltextzugriff (PDF)

A Predictive Test for Adverse Reactions to Contrast Media Preliminary Results

Investigative radiology, 1988-09, Vol.23 (1), p.S209

1988

Volltextzugriff (PDF)

Hippocampal Electrical Activity and γ‐Aminobutyrate Metabolism in Brain Tissue Following Administration of Homocysteine

Journal of neurochemistry, 1983-03, Vol.40 (3), p.752-757

1983

Volltextzugriff (PDF)

Guidelines for Initiating Fair Employment Practices

Personnel, 1963-05, Vol.40 (3), p.53

James, J Hagan

1963

Volltextzugriff (PDF)

Insulin and oral antidiabetic drugs

International anesthesiology clinics, 1975, Vol.13 (4), p.127-146

1975

Volltextzugriff (PDF)

Measurement of arginase activity

Analytical biochemistry, 1968-03, Vol.22 (3), p.518-524

1968

Volltextzugriff (PDF)

High-Resolution Patterned Cellular Constructs by Droplet-Based 3D Printing

Scientific reports, 2017-08, Vol.7 (1), p.7004-7004, Article 7004

2017

Volltextzugriff (PDF)

Comparison of Certain Properties of Human Plasminogen and “Proactivator”

Proceedings of the Society for Experimental Biology and Medicine, 1957-06, Vol.95 (2), p.195-200

1957

Volltextzugriff (PDF)

1 – 25 von 234

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(200)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/ serotonin reuptake inhibitor, vilazodone

Effect of 5-HT1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets

5-HT7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta

SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): a novel, potent and selective 5-HT1B receptor antagonist

Fluorescence detection of gadolinium chelates separated by reversed-phase high-performance liquid chromatography

Effect of 5-HT 1B/D receptor agonist and antagonist administration on motor function in haloperidol and MPTP-treated common marmosets

SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5- methoxyindol-1-yl]-1-[2'methyl-4'-(5-methyl-1,2,3-oxadiazol-3-yl)b iphenyl-4 - yl]methanone hydrochloride): A novel, potent and selective 5-HT sub(1B) receptor antagonist

SB-616234-A (1-[6-( cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT 1B receptor antagonist

5-HT 7 receptor subtype as a mediator of the serotonergic regulation of luteinizing hormone release in the zona incerta

SB-649915, a novel, potent 5-HT sub(1A) and 5-HT sub(1B) autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

SB-649915, a novel, potent 5-HT 1A and 5-HT 1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue

Neurochemical evaluation of the novel 5-HT 1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone

Prekallikrein Activation, C1 Esterase Inhibitor, and Factor XII as Predictors of Adverse Reaction to Contrast Media: A Prospective Study

A Predictive Test for Adverse Reactions to Contrast Media Preliminary Results

A Predictive Test for Adverse Reactions to Contrast Media Preliminary Results

Hippocampal Electrical Activity and γ‐Aminobutyrate Metabolism in Brain Tissue Following Administration of Homocysteine

Guidelines for Initiating Fair Employment Practices

Insulin and oral antidiabetic drugs

Measurement of arginase activity

High-Resolution Patterned Cellular Constructs by Droplet-Based 3D Printing

Comparison of Certain Properties of Human Plasminogen and “Proactivator”

Suchergebnisse filtern